Core Laboratories CLB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $121.8M-1.4% | $138.26M+7.0% | $134.52M+0.1% | $130.16M-0.3% | $123.59M-4.7% | ||
| $1.89M-57.3% | $15.83M+11.7% | $20.93M+5.7% | $15.29M-4.5% | $4.42M-48.5% | ||
| 1.5%-2.0pp | 11.5%+0.5pp | 15.6%+0.8pp | 11.7%-0.5pp | 3.6%-3.0pp | ||
| $2.89M+11.1% | $2.61M-0.8% | $2.65M-14.7% | $2.71M-15.5% | $2.6M-24.0% | ||
| -$1M-155% | $13.22M+14.5% | $18.28M+9.5% | $12.58M-1.7% | $1.82M-64.7% | ||
| -$251K-114% | $8.09M+98.6% | $3.75M-20.0% | $1.91M-47.0% | $1.75M+5.3% | ||
| -$789K-412% | $4.95M-33.2% | $14.24M+21.2% | $10.64M+17.8% | -$154K-105% | ||
| -0.6%-0.5pp | 3.6%-2.1pp | 10.6%+1.8pp | 8.2%+1.3pp | -0.1%-2.6pp | ||
| -$0.02— | $0.11-31.3% | $0.30+20.0% | $0.22+15.8% | $0.00-100% | ||
| $5.65M-30.5% | $19.5M+9.3% | $24.52M+4.4% | $18.96M-4.1% | $8.13M-34.5% | ||
| 4.6%-1.9pp | 14.1%+0.3pp | 18.2%+0.8pp | 14.6%-0.6pp | 6.6%-3.0pp | ||
| $1.89M-57.3% | $15.83M+11.7% | $20.93M+5.7% | $15.29M-4.5% | $4.42M-48.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Core Laboratories's revenue?
- Core Laboratories (CLB) generated $524.7M in revenue over the trailing twelve months, up 1.3% year over year.
- Is Core Laboratories profitable?
- Core Laboratories reported $29.0M in net income over the trailing twelve months, a 5.5% net margin.
- What is Core Laboratories's earnings per share?
- Core Laboratories's diluted EPS over the trailing twelve months is $0.61.
- Where does Core Laboratories's income statement data come from?
- Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
